Cyclophosphamide Methotrexate Fluorouracil <unk>  is a commonly used regimen of breast cancer chemotherapy that combines three anti-cancer agents: cyclophosphamide, methotrexate, and 5-fluorouracil (5-FU). While it is no longer considered the most efficient all-around chemotherapy, it retains a great importance in the treatment of elderly patients with luminal cancers and may become important for the treatment of estrogen receptor negative androgen receptor positive luminal (GATA3 expressing) breast cancer. The regimen was designed in order to mimic the highly successful regimen developed to treat Hodgkin's lymphoma.
CMF 
HFE 
NLM
FCM 
D-DIA
CGM
IPP-SHR
SFHAM